EXCELSUS
Holdings
own 2024 accountsThis companyEXCELSUS1 holding, 1 country
2024 accounts
Since the merger of 30-06-2025, these holdings have been held by SOPHARMA.
Europe 1 Equity Result
- NL 26.72% €0 result €0
Source: list of holdings in its own 2024 accounts. The amounts are in that list and come from the holdings' accounts at 31-12-2020, in their own currency.
Holdings and subsidiaries
1 holdingHoldings 1
Since the merger of 30-06-2025, these holdings have been held by .
Share, source and own figures per holding (1)
-
26.72%
Holdings through the years 2022 to 2024
| Name | 2022 | 2023 | 2024 |
|---|---|---|---|
| 26.72% | |||
Source: list of holdings in its own accounts
Board mandates elsewhere
2 board mandatesSince the merger of 30-06-2025, has continued these mandates.
Board mandates of EXCELSUSEXCELSUS sits on their board2
Director
Founded in 2001 · total assets €172.1m (2025)
Director
Founded in 1977 · 48 FTE (2025)
Acquisitions and mergers
3 transactionsConnections & network
4 last directorsThe board mandates are listed under Board mandates elsewhere. The network lets you explore the same ties.
This company
Company
Director
Shareholding
+N: links not shown yet
Bankruptcy, dissolution or liquidation
Click a node to look further, drag to arrange, zoom with the mouse wheel.